S426-0325 Screening compound: 1-(3,4-dimethoxybenzoyl)-3-[5-(ethoxymethyl)-1,2,4-oxadiazol-3-yl]piperidine

S426-0325 Screening compound: 1-(3,4-dimethoxybenzoyl)-3-[5-(ethoxymethyl)-1,2,4-oxadiazol-3-yl]piperidine
S426-0325 Screening compound: 1-(3,4-dimethoxybenzoyl)-3-[5-(ethoxymethyl)-1,2,4-oxadiazol-3-yl]piperidine alternative view

Chemical Structure Depiction of ChemDiv screening compound S426-0325
1-(3,4-dimethoxybenzoyl)-3-[5-(ethoxymethyl)-1,2,4-oxadiazol-3-yl]piperidine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S426-0325

Molecular Formula

C19H25N3O5 (C19 H25 N3 O5)

Compound Name

1-(3,4-dimethoxybenzoyl)-3-[5-(ethoxymethyl)-1,2,4-oxadiazol-3-yl]piperidine

IUPAC name

1-(34-dimethoxybenzoyl)-3-[5-(ethoxymethyl)-124-oxadiazol-3-yl]piperidine

SMILES

CCOCc1nc(C(CCC2)CN2C(c(cc2)cc(OC)c2OC)=O)no1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

375.42

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.693

Distribution Coefficient, logD

1.693

Water Solubility, LogSw

-2.07

Polar Surface Area

71.483

Acid Dissociation Constant (pKa)

26.96

Base Dissociation Constant (pKb)

-2.13

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

52.60

S426-0325 in Drug Discovery

Included in Screening Libraries

Ligand-Gated Ion Channels Library (3887 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Eye
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Ion Channels
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S426-0325 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S426-0325?
Check Price and Availability of S426-0325, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S426-0325 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S426-0325
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S426-0325
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S426-0325 available by request